 |
|
Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF- κB signaling pathways
Seung Min Lee, Dong Hee Koh, Dae Won Jun, Yoon Jin Roh, Hyeon Tae Kang, Ju Hee Oh, Hyun Sung Kim
Clin Mol Hepatol. 2022;28(4):827-840. Published online 2022 Jun 22 DOI: https://doi.org/10.3350/cmh.2022.0068
|
|
Citations to this article as recorded by
 Estrogen-dependent activation of TRX2 reverses oxidative stress and metabolic dysfunction associated with steatotic disease
Alfredo Smiriglia, Nicla Lorito, Marina Bacci, Angela Subbiani, Francesca Bonechi, Giuseppina Comito, Marta Anna Kowalik, Andrea Perra, Andrea Morandi
Cell Death & Disease.2025;[Epub] CrossRef The protective role of kakkalide in sepsis-induced intestinal barrier dysfunction via inhibition of NF-κB pathway activation
Tongrong Xu, Jiahui Han, Nan Wang, Zhirong Huan, Hao Yao, Xin Ge
Journal of Clinical Biochemistry and Nutrition.2025; 76(2): 139. CrossRef Fucoidan ameliorates lipid accumulation, oxidative stress, and NF-κB-mediated inflammation by regulating the PI3K/AKT/Nrf2 signaling pathway in a free fatty acid-induced NAFLD spheroid model
Xueru Chu, Xuan Wang, Keqing Feng, Yanzhen Bi, Yongning Xin, Shousheng Liu
Lipids in Health and Disease.2025;[Epub] CrossRef Sanye tablet regulates gut microbiota and bile acid metabolism to attenuate hepatic steatosis
Yulin Qi, Siqi Du, Wenwen Li, Xianzhe Qiu, Fengjie Zhou, Liding Bai, Boli Zhang, Zhuoxin Mi, Weiqiang Qian, Lin Li, Xin Zhao, Yuhong Li
Journal of Ethnopharmacology.2025; 345: 119514. CrossRef Acteoside inhibits hepatic lipid accumulation and oxidative stress in type 2 diabetic mice via the Nrf2/HO-1 Pathway
Dan-Dan Hao, Lei Zhang, Si-Lin Liu, Zhi-Juan Sun, Ri-Gu-Leng Si, Feng-Ning Zhang, Li-Xin Yang, Xiao-Li Jia, Tian-Zhu Li, Lin Ai, Chun-Ying Bai, Kai Gu, Cong-Ying Zhang
Journal of Toxicology and Environmental Health, Part A.2025; : 1. CrossRef Protective effects of Scutellaria barbata against hepatocyte apoptosis during hepatic fibrosis progression
Feng Li, Bi Wang, Xianxian Fu, Jinqiang Liang, Xi Xiao, Xiaobin Wei
Cytotechnology.2025;[Epub] CrossRef The rheumatoid arthritis drug Auranofin targets peroxiredoxin 1 and peroxiredoxin 2 to trigger ROS-endoplasmic reticulum stress axis-mediated cell death and cytoprotective autophagy
Wenyue Yang, Zhou Zhu, Chaohua Zhou, Junhui Chen, Jinhuan Ou, Haibo Tong, Ashok Iyaswamy, Peng Chen, Xu Wei, Chuanbin Yang, Wei Xiao, Jigang Wang, Wei Zhang
Free Radical Biology and Medicine.2025; 233: 1. CrossRef ELANE enhances KEAP1 protein stability and reduces NRF2-mediated ferroptosis inhibition in metabolic dysfunction-associated fatty liver disease
Qingqing Yang, Xuan Shen, Yan Luo, Rongqing Li, Xiangrui Meng, Ping Xu, Xuan Liu, Dongxue Bian, Jianhua Wang, Junping Shi, Jin Chen
Cell Death & Disease.2025;[Epub] CrossRef Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents
Paola Checconi, Annaluisa Mariconda, Alessia Catalano, Jessica Ceramella, Michele Pellegrino, Stefano Aquaro, Maria Stefania Sinicropi, Pasquale Longo
Molecules.2025; 30(8): 1726. CrossRef Activation of AMPK pathway by low‑dose donafenib and atorvastatin combination improves high‑fat diet‑induced metabolic dysfunction‑associated steatotic liver disease
Yaowei Bai, Kequan Chen, Jiacheng Liu, Yingliang Wang, Chaoyang Wang, Shuguang Ju, Chen Zhou, Wei Yao, Bin Xiong, Chuansheng Zheng
Molecular Medicine Reports.2024;[Epub] CrossRef Network pharmacology and transcriptomic profiling elucidate the therapeutic effects of Ranunculus ternatus Thunb on liver fibrosis via MK3-NF-κB inhibition
Lu Han, Guoyuan Lin, Jianchao Li, Qingxiu Zhang, Tao Ran, Tao Huang, Ruihan Hu, Shu Feng, Gaoliang Zou, Shaojie Chen, Xueke Zhao
Aging.2024;[Epub] CrossRef Increasing prevalence of cirrhosis among insured adults in the United States, 2012–2018
Daniela P. Ladner, Michael Gmeiner, Bima J. Hasjim, Nikhilesh Mazumder, Raymond Kang, Emily Parker, John Stephen, Praneet Polineni, Anna Chorniy, Lihui Zhao, Lisa B. VanWagner, Ronald T. Ackermann, Charles F. Manski, Sona Frankova
PLOS ONE.2024; 19(2): e0298887. CrossRef Oxysophoridine inhibits oxidative stress and inflammation in hepatic fibrosis via regulating Nrf2 and NF-κB pathways
Jian-Yu Chen, Ying-Jie Yang, Xiong-Yu Meng, Ru-Hui Lin, Xiao-Yun Tian, Ying Zhang, Wen-Fang Lai, Chunxue Yang, Xue-Qin Ma, Ming-Qing Huang
Phytomedicine.2024; 132: 155585. CrossRef NF-ĸB axis in diabetic neuropathy, cardiomyopathy and nephropathy: A roadmap from molecular intervention to therapeutic strategies
Aryan Rezaee, Parham Rahmanian, Amirreza Nemati, Farima Sohrabifard, Fatemeh Karimi, Ali Elahinia, Ali Ranjbarpazuki, Rozhin Lashkarbolouki, Sadaf Dezfulian, Mohammad Arad Zandieh, Shokooh Salimimoghadam, Noushin Nabavi, Mohsen Rashidi, Afshin Taheriazam,
Heliyon.2024; 10(9): e29871. CrossRef Tricetin protects against liver fibrosis through promoting autophagy and Nrf2 signaling in hepatic stellate cells
Wanzhi Li, Ruyue Lv, Tangbin Zou, Ming Chen
Life Sciences.2024; 351: 122798. CrossRef Exploring the molecular mechanisms and shared potential drugs between rheumatoid arthritis and arthrofibrosis based on large language model and synovial microenvironment analysis
Zhaoquan Wei, Xi Chen, Youshi Sun, Yifei Zhang, Ruifang Dong, Xiaojing Wang, Shuangtao Chen
Scientific Reports.2024;[Epub] CrossRef Evaluating the therapeutic potential of genetically engineered probiotic Zbiotics (ZB183) for non-alcoholic steatohepatitis (NASH) management via modulation of the cGAS-STING pathway
Maha Saad, Walaa Ibrahim, Amany Helmy Hasanin, Aya Magdy Elyamany, Marwa Matboli
RSC Medicinal Chemistry.2024; 15(11): 3817. CrossRef Cellular fibronectin-targeted fluorescent aptamer probes for early detection and staging of liver fibrosis
Mengjun Ge, Haitao Zou, Jiahao Chen, Qinyao Zhang, Chang Li, Jiaxing Yang, Jiumei Wu, Xing Xie, Jun Liu, Lei Lei, Shaoliang Peng, Hemin Nie
Acta Biomaterialia.2024; 190: 579. CrossRef Induced collagen type‐I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour‐infiltrating lymphocytes
Shodai Mizuno, Matias A. Bustos, Yoshinori Hayashi, Kodai Abe, Satoru Furuhashi, Yalda Naeini, Xiaowei Xu, Anton J Bilchik, Dave S. B. Hoon
Clinical and Translational Medicine.2024;[Epub] CrossRef Letter regarding “Auranofin attenuates hepatic steatosis and fibrosis in nonalcoholic fatty liver disease via NRF2 and NF-κB signaling pathways”
Yuanbin Liu, Mingkai Chen
Clinical and Molecular Hepatology.2023; 29(1): 163. CrossRef Oleoylethanolamide alleviates hyperlipidaemia-mediated vascular calcification via attenuating mitochondrial DNA stress triggered autophagy-dependent ferroptosis by activating PPARα
Zhengdong Chen, Xuejiao Sun, Xiaoxue Li, Naifeng Liu
Biochemical Pharmacology.2023; 208: 115379. CrossRef Genetics in non-alcoholic fatty liver disease: The role of risk alleles through the lens of immune response
Silvia Sookoian, Carlos J. Pirola
Clinical and Molecular Hepatology.2023; 29(Suppl): S184. CrossRef CRISPR/Cas9-Based Screening of FDA-Approved Drugs for NRF2 Activation: A Novel Approach to Discover Therapeutics for Non-Alcoholic Fatty Liver Disease
James Li, Sandra Arest, Bartlomiej Olszowy, John Gordon, Carlos A. Barrero, Oscar Perez-Leal
Antioxidants.2023; 12(7): 1363. CrossRef Perfluorodecanoic acid promotes high-fat diet-triggered adiposity and hepatic lipid accumulation by modulating the NLRP3/caspase-1 pathway in male C57BL/6J mice
Taotao Wang, Hong Xu, Yu Guo, Yuanxin Guo, Huanan Guan, Dongxu Wang
Food and Chemical Toxicology.2023; 178: 113943. CrossRef Higher pNRF2, SOCS3, IRF3, and RIG1 Tissue Protein Expression in NASH Patients versus NAFL Patients: pNRF2 Expression Is Concomitantly Associated with Elevated Fasting Glucose Levels
Suzan Schwertheim, Malek Alhardan, Paul P. Manka, Jan-Peter Sowa, Ali Canbay, Hartmut H.-J. Schmidt, Hideo A. Baba, Julia Kälsch
Journal of Personalized Medicine.2023; 13(7): 1152. CrossRef Molecular mechanisms and clinical implications of the gold drug auranofin
Shuying Shen, Jie Shen, Zhong Luo, Fudi Wang, Junxia Min
Coordination Chemistry Reviews.2023; 493: 215323. CrossRef Impaired NRF2 Inhibits Recovery from Ischemic Reperfusion Injury in the Aging Kidney
Min Jee Jo, Ji Eun Kim, So Yon Bae, Eunjung Cho, Shin Young Ahn, Young Joo Kwon, Gang-Jee Ko
Antioxidants.2023; 12(7): 1440. CrossRef Study on inflammation and fibrogenesis in MAFLD from 2000 to 2022: a bibliometric analysis
Kuanhong Luo, Yang Chen, Shuzheng Fang, Siqi Wang, Zhixin Wu, Huiqing Li
Frontiers in Endocrinology.2023;[Epub] CrossRef Auranofin Modulates Thioredoxin Reductase/Nrf2 Signaling in Peripheral Immune Cells and the CNS in a Mouse Model of Relapsing–Remitting EAE
Layla A. Al-Kharashi, Naif O. Al-Harbi, Sheikh F. Ahmad, Sabry M. Attia, Mohammad M. Algahtani, Khalid E. Ibrahim, Saleh A. Bakheet, Mohammed M. Alanazi, Saleh A. Alqarni, Sary Alsanea, Ahmed Nadeem
Biomedicines.2023; 11(9): 2502. CrossRef TrxR/Trx inhibitor butaselen ameliorates pulmonary fibrosis by suppressing NF-κB/TGF-β1/Smads signaling
Yifan Chen, Hanwei Yin, Jing Sun, Guozhou Zhang, Ying Zhang, Huihui Zeng
Biomedicine & Pharmacotherapy.2023; 169: 115822. CrossRef Repurposing drugs to target nonalcoholic steatohepatitis: Auranofin, a gold-organic molecule complex for the treatment of a specifc complex trait
Carlos J. Pirola, Silvia Sookoian
Clinical and Molecular Hepatology.2022; 28(4): 806. CrossRef
|